Back to Journals » International Journal of Nanomedicine » Volume 14

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Total article views   HTML views PDF downloads Totals
8,495 Dovepress* 7,855+ 1,212 9,067
PubMed Central* 640 144 784
Totals 8,495 1,356 9,851
*Since 6 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar